4 min read
The Evolution to Event-Based Architecture is Transforming Patient Care
Reducing time to therapy is a critical goal for pharmaceutical manufacturers and the patients who rely on their specialty drugs. The sooner the...
4 min read
Reducing time to therapy is a critical goal for pharmaceutical manufacturers and the patients who rely on their specialty drugs. The sooner the...
3 min read
Social determinants like employment, socioeconomic status, education level, food security, and an individual’s support system are known to contribute...
3 min read
Experienced Hubs understand that successful commercial introduction of a therapy often hinges on how confident providers feel integrating a new...
3 min read
CareMetx is committed to supporting the patient journey in a way that improves therapy adherence, persistence, and health outcomes. To inform this...
3 min read
When a patient has a serious or complex health problem that needs attention, the journey to receive a diagnosis and obtain the right specialty...
3 min read
More than 18% of the US population is covered in some form by Medicare. For more than 23 million Americans, it’s through the Medicare Advantage plan;...
4 min read
When CVS Health released its 2021’s annual Drug Trend Report, it revealed that specialty medications accounted for more than half (52% to be exact)...
3 min read
Accurate, transparent data is quickly becoming a critical piece of pharmaceutical manufacturers’ decision making processes. To ensure patients have...
2 min read
Healthcare, Digitalization and Increasing Need
4 min read
The past several years have been dramatic for the pharmaceutical industry as the number of specialty therapies on the market continue to rise- in...
3 min read
Today, about half of all drugs for chronic conditions aren’t taken as prescribed, and 20% to 30% of those prescriptions go unfilled altogether. Even...
3 min read
Every day, more widespread implementation of health information technology is facilitating simpler access to patient health information and rapidly...